"Spectrum played a very important role in setting the CMC regulatory stage for us to carry out our Phase 3 clinical trials in Canada and Europe, as well as reviewing/impacting our NDA & EMA submissions. Your high quality approach has made the journey to US NDA Approval a little less arduous and a little more fun. Thanks for everything!"
Chief Operating Officer
U.S. Biotechnology Company
Medical Market Consultants
Managing the Business of Science™
Experience. Service. Quality.
NDS a Winner. Evaluating Investment Opportunity.
Management of Multiple Departments
Resolving a Thorny Problem
GMP and Quality Assurance
Product Acquisition Opportunity
2011-2014 Spectrum MMC. All rights reserved.